Spruce Biosciences, Inc. Common Stock
N/A
USD
N/A
N/A
...
Chart
Financials
Description
SPRB Company Description
Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with unmet medical needs. The company is initially developing its wholly-owned product candidate, tildacerfont, as the potential first non-steroidal therapy to offer markedly improved disease control and reduce steroid burden for patients suffering from classic congenital adrenal hyperplasia (CAH).
SPRB Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view SPRB Smart Score
Score Breakdown
Bull Case vs Bear Case
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
Bulls Say:
The Bulls Say summary highlights positive aspects of the stock.
Bears Say:
The Bears Say summary points out potential risks and negative aspects of the stock.
Show More
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of SPRB by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by SPRB's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
WallStreetBets
Number of mentions of SPRB in WallStreetBets Daily Discussion
SPRB News
Recent insights relating to SPRB
CNBC Recommendations
Recent picks made for SPRB stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in SPRB
Corporate Flights
Flights by private jets registered to SPRB
Our Analysis